| AD | Alzheimer’s disease |
| Akt | RAC-alpha serine/threonine-protein kinase |
| ALS | Amyotrophic lateral sclerosis |
| aPC | Activated protein C |
| ApoM | Apolipoprotein M |
| APP | Amyloid precursor protein |
| Aβ | Amyloid-β-peptide |
| BBB | Blood brain barrier |
| CBAs | Conjugated bile acids |
| CBF | Cerebral blood flow |
| CCL4 | C-C motif chemokine 4-like |
| CCL5 | C-C motif chemokine 5-like |
| CCO | Cytochrome c oxidase |
| CCR7 | C-C chemokine receptor type 7 |
| CD | Cluster of differentiation molecule |
| CDase | Ceramidase |
| c-fos | Proto-oncogene c-Fos |
| cIAP2 | Cellular inhibitor of apoptosis 2 |
| CNS | Central nervous system |
| COX-2 | Cyclooxygenase-2 |
| CXCL8 | C-X-C motif chemokine 8, IL-8 |
| CXCL10 | C-X-C motif chemokine 10 |
| DHHC5 | Palmitoyltransferase DHHC5 |
| DNA | Desoxyribonucleic acid |
| EAE | Experimental autoimmune encephalomyelitis |
| EC | Extracellular |
| ERK | Extracellular-regulated kinase |
| GBA | Glucocerebrosidase |
| GCS | Glucosylceramide synthase |
| Glc | Glucose |
| GlcCer | Glucosylceramidase |
| GRK2 | G protein-coupled receptor kinase 2 |
| Gαi/o | Inhibitory Gα subunit |
| Gαq | q subtype of Gα proteins |
| Gαs | Stimulatory Gα subunit |
| G12/13 | 12/13 subtype of Gα proteins |
| HD | Huntigton’s disease |
| HDAC1/2 | Histone deacetylases 1/2 |
| HDL | High-density lipoprotein |
| hTERT | Human telomerase reverse transcriptase |
| IC | Intracellular |
| ICAM1 | Intracellular adhesion molecule 1 |
| IFN-α | Interferon α |
| IL-1 | Interleukin-1 |
| IL-6 | Interleukin-6 |
| IL-17A | Interleukin-17A |
| IRF1 | Interferon regulatory factor 1 |
| IκB | Inhibitor of nuclear factor κ-B kinase |
| IκBα | NF-κB inhibitor α |
| LBD | Lewy body disorders |
| LDL | Low-density lipoprotein |
| LPP | Lipid phosphate phosphohydrolase |
| MCAO | Middle cerebral artery occlusion |
| MFSD2B | Major facilitator superfamily domain-containing protein 2B |
| MKRN1 | Makorin ring finger protein 1 |
| MMP-9 | Matrix metalloproteinase-9 |
| mRNA | Messenger ribonucleic acid |
| MS | Multiple slerosis |
| NF-κB | Nuclear factor κ-light-chain-enhancer of activated B cells |
| NMO | Neuromyelitis optica |
| NVU | Neurovascular unit |
| ORMDL3 | ORM1-like protein 3 |
| OXPHOS | Oxidative phosphorylation |
| PalCoA | Palmitoyl-CoA |
| PD | Parkinson’s disease |
| PE | Phosphoethanolamine |
| PGC1β | PPARγ co-activator 1β |
| PHB2 | Prohibitin-2 |
| PKC | Protein kinase C |
| PKCζ | Atypical PKC subtype ζ |
| PKCι | Atypical PKC subtype ι |
| PLPP3 | Phospholipid phosphatase 3 |
| PM | Plasma membrane |
| PPARγ | Peroxisome proliferator activated receptor γ |
| PTX3 | Pentraxin-related protein 3 |
| p21 | Cyclin-dependent kinase inhibitor 1 |
| RACK | Receptor for activated C kinase proteins |
| RhoA | Transforming protein RhoA |
| RING | Really interesting new group |
| RIP1 | Receptor-interacting serine/threonine-protein kinase 1 |
| rt-PA | Recombinant-tissue plasminogen activator |
| SAH | Subarachnoid hemorrhage |
| sER | Smooth endoplasmic reticulum |
| SGPL1 | S1P lyase 1 |
| SGPP1/2 | Sphingosine 1-phosphate phosphohydrolase 1/2 |
| SLE | Systemic lupus erythematosus |
| SMase | Sphingomyelinase |
| SMS | Sphingomyelin synthase |
| SphK1 | Sphingosine kinase 1 |
| SphK2 | Sphingosine kinase 2 |
| SPNS2 | Spinster homolog 2 |
| SPT | Serine palmitoyltransferase |
| STAT3 | Signal transducer and activator of transcription 3 |
| S1P | Sphingosine 1-phosphate |
| S1PR | Sphingosine 1-phosphate receptor |
| S1P1–5 | S1PR subtype 1–5 |
| TAB3 | TGF-β-activated kinase 1 and MAP3K7-binding protein3 |
| TFH | Follicular TH cell |
| TGF-β | Transforming-growth-factor-β |
| TH-17 | TH-17 type cell |
| TNFRSF12A | Tumor necrosis factor receptor superfamily member 12A |
| TNF-α | Tumor necrosis factor-α |
| TRAF2 | TNF-α receptor-associated factor 2 |
| TRAF6 | TNF-α receptor-associated factor 6 |
| TREG | Regulatory T cell |
| TUNEL | Terminal deoxynucleotidyl transferase-mediated, uridine 5′triphosphate-biotin nick end-labeling |
| UGT8A | UDP galactosyltransferase 8A |
| VEGFa | Vascular endothelial growth factor A |
| VLDL | Very low-density lipoprotein |
| WWP2 | NEDD4-like E3 ubiquitin ligase WWP2 |